(Q42610451)

3 November 2017

title

Preliminary evidence for an involvement of the cholinergic system in the sedative effects of rolipram in rats (English)

1 reference

3 November 2017

1 reference

Silvestre JS

1

1 reference

3 November 2017

Fernández AG

series ordinal

2

1 reference

3 November 2017

Palacios JM

series ordinal

3

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

Pharmacology, Biochemistry and Behavior

3 November 2017

published in

1 reference

3 November 2017

volume

64

1 reference

3 November 2017

issue

1

1 reference

3 November 2017

page(s)

1-5

1 reference

Effects of repeated administration of rolipram, a cAMP-specific phosphodiesterase inhibitor, on acetylcholinergic indices in the aged rat brain.

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Potentiation of acetylcholine responses in Xenopus embryonic muscle cells by dibutyryl cAMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Behavioral effects of rolipram and structurally related compounds in mice: behavioral sedation of cAMP phosphodiesterase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Effect of [1,3-di-n-butyl-7-(2-oxopropyl)-xanthine] (denbufylline), a low Km phosphodiesterase inhibitor, on striatal acetylcholine release in the rat: analysis using cerebral microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Autoradiographic mapping of a selective cyclic adenosine monophosphate phosphodiesterase in rat brain with the antidepressant [3H]rolipram

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Mecamylamine reverses physostigmine-induced attenuation of scopolamine-induced hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

The Influence of Rolipram on the Central Serotoninergic System

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Brain cyclic AMP and memory in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Stereospecific binding of the antidepressant rolipram to brain protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Discriminative stimulus properties of the stereoisomers of the phosphodiesterase inhibitor rolipram.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Effects of lithium and rolipram enantiomers on locomotor activity in inbred mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3?,5?-monophosphate phosphodiesterase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Neurotropic effects of the optical isomers of the selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitor rolipram in rats in-vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

The second-messenger dysbalance hypothesis of affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

The topography of amphetamine and scopolamine-induced hyperactivity: toward an activity print

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900243-3

7 January 2021

10.1016/S0091-3057(98)00243-3

Identifiers

DOI

1 reference

3 November 2017

1 reference